CEO Mark Bertolini Makes $11.9M Private Placement Purchase and Vests $77M in PSUs, Significantly Increasing Stake

summarizeSummary

CEO Mark Bertolini demonstrated strong conviction by purchasing $11.9 million in Class A Common Stock via a private placement and vesting over $76 million in performance stock units, substantially increasing his direct ownership in Oscar Health.

check_boxKey Events

• CEO Private Placement Purchase

  CEO Mark Bertolini purchased 1,000,000 shares of Class A Common Stock for $11,920,000.00 in a private placement transaction at $11.92 per share on April 6, 2026.

• Significant PSU Vesting

  Mark Bertolini acquired 5,733,334 shares through the vesting of performance stock units (PSUs) on April 3, 2026, representing a substantial increase in his direct holdings.

• Increased Insider Ownership

  The combined transactions, net of tax withholdings, resulted in a significant increase in the CEO's direct ownership, demonstrating strong conviction in the company's prospects.

auto_awesomeAnalysis

This Form 4 filing reveals a highly significant increase in CEO Mark Bertolini's direct ownership of Oscar Health. The $11.9 million private placement purchase of 1,000,000 shares at $11.92 per share is a strong discretionary signal of confidence in the company's future, especially following a reported net loss of $443.15 million for fiscal year 2025. Additionally, the vesting of 5,733,334 performance stock units, valued at approximately $77 million, further aligns the CEO's interests with long-term shareholder value. While a portion of shares were withheld for tax obligations, the net effect is a substantial increase in the CEO's stake, signaling strong insider conviction. This move could be interpreted as a bullish indicator, particularly given the company's recent financial performance.